Context Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Context Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Context Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Context Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $9.0M | 4.5M | 2.01 |
| 2024-03-31 | $826k | 598k | 1.38 |
| 2023-12-31 | $674k | 596k | 1.13 |
| 2023-09-30 | $896k | 594k | 1.51 |
| 2023-06-30 | $920k | 575k | 1.60 |
| 2023-03-31 | $322k | 573k | 0.56 |
| 2022-12-31 | $418k | 641k | 0.65 |
| 2022-06-30 | $1.3M | 629k | 2.12 |
| 2022-03-31 | $513k | 236k | 2.17 |